Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2015 | 12-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 50,660 | 7,843 |
| Other current assets | 1,062 | 1,609 |
| TOTAL | $53,038 | $10,764 |
| Non-Current Assets | ||
| PPE Net | 52 | 61 |
| Intangibles | 10 | 0 |
| Other Non-Current Assets | 217 | 12 |
| TOTAL | $279 | $73 |
| Total Assets | $53,317 | $10,837 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3,648 | 4,269 |
| Other current liabilities | 770 | N/A |
| TOTAL | $4,418 | $4,701 |
| Non-Current Liabilities | ||
| Long Term Debt | 5,588 | 4,992 |
| Other Non-Current Liabilities | 1,101 | 1,132 |
| TOTAL | $6,689 | $6,124 |
| Total Liabilities | $11,107 | $10,825 |
| Shareholders' Equity | ||
| Common Shares | 889 | 658 |
| Retained earnings | -7,062 | -117,477 |
| Other shareholders' equity | -117,593 | 47 |
| TOTAL | $42,210 | $12 |
| Total Liabilities And Equity | $53,317 | $10,837 |